ABOUT US
CONTACT US
FAQ
PRIVACY POLICY
REFUND AND CANCELLATION
BLOGS
COMPANIES
REPORTS
0
U.S. (TOLL FREE)
+1 (315) 215-3225
Automative
0
U.S. (TOLL FREE)
+1 (315) 215-3225
Global High-throughput Screening (HTS) Assay Market Outlook, In‑Depth Analysis & Forecast to 2031
Published Date: November 2025
|
Report Code: QYRE-Auto-32N16843
Home | Market Reports | Business & Industrial| Pharmaceuticals & Biotech
Global High throughput Screening HTS Assay Market Research Report 2024
BUY CHAPTERS

Global High-throughput Screening (HTS) Assay Market Outlook, In‑Depth Analysis & Forecast to 2031

Code: QYRE-Auto-32N16843
Report
November 2025
Pages:156
QYResearch
Buy Now with 15% Discount
DESCRIPTION
TABLE OF CONTENT
TABLES & FIGURES
FEATURED COMPANIES
Thermo Fisher Scientific
PerkinElmer Inc
Agilent Technologies
Beckman Coulter
Tecan Group
Hamilton Company
Bio Rad Laboratories
BMG LABTECH
Promega Corporation
Danaher
Axxam S.P.A.
Merck Millipore
Aurora Biomed
InvivoGen
Biotek Instruments
BPS Bioscience
Eurofins Discovery
Cayman Chemical

High-throughput Screening (HTS) Assay Market

The global High-throughput Screening (HTS) Assay market is projected to grow from US$ million in 2024 to US$ million by 2031, at a CAGR of %(2025-2031), driven by critical product segments and diverse end‑use applications.
High-throughput screening (HTS) assay is a method used in drug discovery and other fields to quickly and efficiently test a large number of compounds or samples for a specific biological activity. HTS assays are typically automated and can screen thousands to millions of compounds in a relatively short amount of time. HTS assays are often used in the early stages of drug discovery to identify potential lead compounds that show promising activity against a target of interest. These assays can be used to screen for a wide range of biological activities, such as enzyme inhibition, receptor binding, or cell-based assays. There are several different types of HTS assays, including biochemical assays, cell-based assays, and phenotypic assays. Biochemical assays measure the activity of a specific enzyme or protein, while cell-based assays use living cells to measure the effect of compounds on cellular processes. Phenotypic assays measure a specific observable phenotype, such as cell growth or morphology. Overall, HTS assays are a powerful tool in drug discovery and other fields, allowing researchers to quickly and efficiently screen large libraries of compounds to identify potential drug candidates.
From a downstream perspective, Drug Discovery accounted for % of 2024 revenue, surging to US$ million by 2031 (CAGR: % from 2025–2031).
High-throughput Screening (HTS) Assay leading manufacturers including Thermo Fisher Scientific, PerkinElmer, Agilent Technologies, Beckman Coulter, Tecan Group, Hamilton Company, Bio-Rad Laboratories, BMG LABTECH, Promega Corporation, Danaher, etc., dominate supply; the top five capture approximately % of global revenue, with Thermo Fisher Scientific leading 2024 sales at US$ million.
Regional Outlook:
North America rose from US$ million in 2024 to a forecast US$ million by 2031 (CAGR %).
Asia‑Pacific will expand from US$ million to US$ million (CAGR  %), led by China (US$ million in 2024, % share rising to % by 2031), Japan (CAGR %), South Korea (CAGR %), and Southeast Asia (CAGR %).
Europe is set to grow from US$ million to US$ million (CAGR %), with Germany projected to hit US$ million by 2031 (CAGR %).

Report Includes:

This definitive report equips CEOs, marketing directors, and investors with a 360° view of the global High-throughput Screening (HTS) Assay market across value chain. It analyzes historical revenue data (2020–2024) and delivers forecasts through 2031, illuminating demand trends and growth drivers.
By segmenting the market by Type and by Application, the study quantifies market size, growth rates, niche opportunities, and substitution risks, and analyzes downstream customers distribution pattern.
Granular regional insights cover five major markets—North America, Europe, APAC, South America, and MEA—with in‑depth analysis of 20+ countries, detailing dominant products, competitive landscape, and downstream demand trends.
Critical competitive intelligence profiles players—revenue, margins, pricing strategies, and major customers—and dissects the top-player positioning across product lines, applications, and regions to reveal strategic strengths.
A concise Industry‑chain overview maps upstream, middlestream, and downstream distribution dynamics to identify strategic gaps and unmet demand.
Market Segmentation

Scope of High-throughput Screening (HTS) Assay Market Report

Report Metric Details
Report Name High-throughput Screening (HTS) Assay Market
Segment by Type
  • Biochemical Assay
  • Phenotyping Assay
  • Binding Assay
  • Aell-based Assay
  • Others
Segment by Application
  • Drug Discovery
  • Identifying New Drug Targets
  • Toxicology Research
  • Others
Sales by Region
  • North America (United States, Canada)
  • Europe (Germany, France, UK, Italy, Russia) Rest of Europe
  • Nordic Countries
  • Asia-Pacific (China, Japan, South Korea)
  • Southeast Asia (India, Australia)
  • Rest of Asia
  • Latin America (Mexico, Brazil)
  • Rest of Latin America
  • Middle East & Africa (Turkey, Saudi Arabia, UAE, Rest of MEA)
By Company Thermo Fisher Scientific, PerkinElmer, Agilent Technologies, Beckman Coulter, Tecan Group, Hamilton Company, Bio-Rad Laboratories, BMG LABTECH, Promega Corporation, Danaher, Axxam, Merck Millipore, Aurora Biomed, InvivoGen, Biotek Instruments, BPS Bioscience, Eurofins Discovery, Cayman Chemical
Forecast units USD million in value
Report coverage Revenue and volume forecast, company share, competitive landscape, growth factors and trends

Chapter Outline

  • Chapter 1: Defines the High-throughput Screening (HTS) Assay study scope, segments the market by Type and by Application, etc, highlights segment size and growth potential.
  • Chapter 2: Offers current market state, projects global revenue and sales to 2031, pinpointing high consumption regions and emerging market catalysts
  • Chapter 3: Dissects the player landscape—ranks by revenue and profitability, details Player performance by product type and evaluates concentration alongside M&A moves.
  • Chapter 4: Unlocks high margin product segments—compares revenue, ASP, and technology differentiators, highlighting growth niches and substitution risks
  • Chapter 5: Targets downstream market opportunities—evaluates market size by Application, identifies emerging use cases, and profiles leading customers by region and by Application.
  • Chapter 6: North America—breaks down market size by Type, by Application and country, profiles key players and assesses growth drivers and barriers.
  • Chapter 7: Europe—analyses regional market by Type, by Application and players, flagging drivers and barriers.
  • Chapter 8: Asia Pacific—quantifies market size by Type, by Application, and region/country, profiles top players, and uncovers high potential expansion areas.
  • Chapter 9: Central & South America—measures market size by Type, by Application, and country, profiles top players, and identifies investment opportunities and challenges.
  • Chapter 10: Middle East and Africa—evaluates market size by Type, by Application, and country, profiles key players, and outlines investment prospects and market hurdles
  • Chapter 11: Profiles players in depth—details product specs, revenue, margins; Top-tier players 2024 sales breakdowns by Product type, by Application, by region SWOT analysis, and recent strategic developments.
  • Chapter 12: Industry chain—analyses upstream, cost drivers, plus downstream channels.
  • Chapter 13: Market dynamics—explores drivers, restraints, regulatory impacts, and risk mitigation strategies.
  • Chapter 14: Actionable conclusions and strategic recommendations.
  • Why This Report:
  • Beyond standard market data, this analysis provides a clear profitability roadmap—empowering you to:
  • Allocate capital strategically to high growth regions (Chapters 6–10) and margin rich segments (Chapter 5).
  • Negotiate from strength with suppliers (Chapter 12) and customers (Chapter 5) using cost and demand intelligence.
  • Outmaneuver competitors with granular insights into their operations, margins, and strategies (Chapters 3 and 11).
  • Capitalize on the projected billion‑dollar opportunity with data‑driven regional and segment tactics (Chapter 12-14).
  • Leverage this 360° intelligence to turn market complexity into actionable competitive advantage.

FAQ for this report

Who are the main players in the High-throughput Screening (HTS) Assay Market report?

Ans: The main players in the High-throughput Screening (HTS) Assay Market are Thermo Fisher Scientific, PerkinElmer, Agilent Technologies, Beckman Coulter, Tecan Group, Hamilton Company, Bio-Rad Laboratories, BMG LABTECH, Promega Corporation, Danaher, Axxam, Merck Millipore, Aurora Biomed, InvivoGen, Biotek Instruments, BPS Bioscience, Eurofins Discovery, Cayman Chemical

What are the Application segmentation covered in the High-throughput Screening (HTS) Assay Market report?

Ans: The Applications covered in the High-throughput Screening (HTS) Assay Market report are Drug Discovery, Identifying New Drug Targets, Toxicology Research, Others

What are the Type segmentation covered in the High-throughput Screening (HTS) Assay Market report?

Ans: The Types covered in the High-throughput Screening (HTS) Assay Market report are Biochemical Assay, Phenotyping Assay, Binding Assay, Aell-based Assay, Others

1 Study Coverage
1.1 Introduction to High-throughput Screening (HTS) Assay: Definition, Properties, and Key Attributes
1.2 Market Segmentation by Type
1.2.1 Global High-throughput Screening (HTS) Assay Market Size by Type, 2020 VS 2024 VS 2031
1.2.2 Biochemical Assay
1.2.3 Phenotyping Assay
1.2.4 Binding Assay
1.2.5 Aell-based Assay
1.2.6 Others
1.3 Market Segmentation by Application
1.3.1 Global High-throughput Screening (HTS) Assay Market Size by Application, 2020 VS 2024 VS 2031
1.3.2 Drug Discovery
1.3.3 Identifying New Drug Targets
1.3.4 Toxicology Research
1.3.5 Others
1.4 Assumptions and Limitations
1.5 Study Objectives
1.6 Years Considered
2 Executive Summary
2.1 Global High-throughput Screening (HTS) Assay Revenue Estimates and Forecasts 2020-2031
2.2 Global High-throughput Screening (HTS) Assay Revenue by Region
2.2.1 Revenue Comparison: 2020 VS 2024 VS 2031
2.2.2 Historical and Forecasted Revenue by Region (2020-2031)
2.2.3 Global Revenue Market Share by Region (2020-2031)
2.2.4 Emerging Market Focus: Growth Drivers & Investment Trends
3 Competition by Players
3.1 Global High-throughput Screening (HTS) Assay Player Revenue Rankings and Profitability
3.1.1 Global Revenue (Value) by Players (2020-2025)
3.1.2 Global Key Player Revenue Ranking (2023 vs. 2024)
3.1.3 Revenue-Based Tier Segmentation (Tier 1, Tier 2, and Tier 3)
3.1.4 Gross Margin by Top Player (2020 VS 2024)
3.2 Global High-throughput Screening (HTS) Assay Companies Headquarters and Service Footprint
3.3 Main Product Type Market Size by Players
3.3.1 Biochemical Assay Market Size by Players
3.3.2 Phenotyping Assay Market Size by Players
3.3.3 Binding Assay Market Size by Players
3.3.4 Aell-based Assay Market Size by Players
3.3.5 Others Market Size by Players
3.4 Global High-throughput Screening (HTS) Assay Market Concentration and Dynamics
3.4.1 Global Market Concentration (CR5 and HHI)
3.4.2 Entrant/Exit Impact Analysis
3.4.3 Strategic Moves: M&A, Expansion, R&D Investment
4 Global Product Segmentation Analysis
4.1 Global High-throughput Screening (HTS) Assay Revenue Trends by Type
4.1.1 Global Historical and Forecasted Revenue by Type (2020-2031)
4.1.2 Global Revenue Market Share by Type (2020-2031)
4.2 Key Product Attributes and Differentiation
4.3 Subtype Dynamics: Growth Leaders, Profitability and Risk
4.3.1 High-Growth Niches and Adoption Drivers
4.3.2 Profitability Hotspots and Cost Drivers
4.3.3 Substitution Threats
5 Global Downstream Application Analysis
5.1 Global High-throughput Screening (HTS) Assay Revenue by Application
5.1.1 Global Historical and Forecasted Revenue by Application (2020-2031)
5.1.2 Revenue Market Share by Application (2020-2031)
5.1.3 High-Growth Application Identification
5.1.4 Emerging Application Case Studies
5.2 Downstream Customer Analysis
5.2.1 Top Customers by Region
5.2.2 Top Customers by Application
6 North America
6.1 North America Market Size (2020-2031)
6.2 North America Key Players Revenue in 2024
6.3 North America High-throughput Screening (HTS) Assay Market Size by Type (2020-2031)
6.4 North America High-throughput Screening (HTS) Assay Market Size by Application (2020-2031)
6.5 North America Growth Accelerators and Market Barriers
6.6 North America High-throughput Screening (HTS) Assay Market Size by Country
6.6.1 North America Revenue Trends by Country
6.6.2 US
6.6.3 Canada
6.6.4 Mexico
7 Europe
7.1 Europe Market Size (2020-2031)
7.2 Europe Key Players Revenue in 2024
7.3 Europe High-throughput Screening (HTS) Assay Market Size by Type (2020-2031)
7.4 Europe High-throughput Screening (HTS) Assay Market Size by Application (2020-2031)
7.5 Europe Growth Accelerators and Market Barriers
7.6 Europe High-throughput Screening (HTS) Assay Market Size by Country
7.6.1 Europe Revenue Trends by Country
7.6.2 Germany
7.6.3 France
7.6.4 U.K.
7.6.5 Italy
7.6.6 Russia
8 Asia-Pacific
8.1 Asia-Pacific Market Size (2020-2031)
8.2 Asia-Pacific Key Players Revenue in 2024
8.3 Asia-Pacific High-throughput Screening (HTS) Assay Market Size by Type (2020-2031)
8.4 Asia-Pacific High-throughput Screening (HTS) Assay Market Size by Application (2020-2031)
8.5 Asia-Pacific Growth Accelerators and Market Barriers
8.6 Asia-Pacific High-throughput Screening (HTS) Assay Market Size by Region
8.6.1 Asia-Pacific Revenue Trends by Region
8.7 China
8.8 Japan
8.9 South Korea
8.10 Australia
8.11 India
8.12 Southeast Asia
8.12.1 Indonesia
8.12.2 Vietnam
8.12.3 Malaysia
8.12.4 Philippines
8.12.5 Singapore
9 Central and South America
9.1 Central and South America Market Size (2020-2031)
9.2 Central and South America Key Players Revenue in 2024
9.3 Central and South America High-throughput Screening (HTS) Assay Market Size by Type (2020-2031)
9.4 Central and South America High-throughput Screening (HTS) Assay Market Size by Application (2020-2031)
9.5 Central and South America Investment Opportunities and Key Challenges
9.6 Central and South America High-throughput Screening (HTS) Assay Market Size by Country
9.6.1 Central and South America Revenue Trends by Country (2020 VS 2024 VS 2031)
9.6.2 Brazil
9.6.3 Argentina
10 Middle East and Africa
10.1 Middle East and Africa Market Size (2020-2031)
10.2 Middle East and Africa Key Players Revenue in 2024
10.3 Middle East and Africa High-throughput Screening (HTS) Assay Market Size by Type (2020-2031)
10.4 Middle East and Africa High-throughput Screening (HTS) Assay Market Size by Application (2020-2031)
10.5 Middle East and Africa Investment Opportunities and Key Challenges
10.6 Middle East and Africa High-throughput Screening (HTS) Assay Market Size by Country
10.6.1 Middle East and Africa Revenue Trends by Country (2020 VS 2024 VS 2031)
10.6.2 GCC Countries
10.6.3 Israel
10.6.4 Egypt
10.6.5 South Africa
11 Corporate Profile
11.1 Thermo Fisher Scientific
11.1.1 Thermo Fisher Scientific Corporation Information
11.1.2 Thermo Fisher Scientific Business Overview
11.1.3 Thermo Fisher Scientific High-throughput Screening (HTS) Assay Product Features and Attributes
11.1.4 Thermo Fisher Scientific High-throughput Screening (HTS) Assay Revenue and Gross Margin (2020-2025)
11.1.5 Thermo Fisher Scientific High-throughput Screening (HTS) Assay Revenue by Product in 2024
11.1.6 Thermo Fisher Scientific High-throughput Screening (HTS) Assay Revenue by Application in 2024
11.1.7 Thermo Fisher Scientific High-throughput Screening (HTS) Assay Revenue by Geographic Area in 2024
11.1.8 Thermo Fisher Scientific High-throughput Screening (HTS) Assay SWOT Analysis
11.1.9 Thermo Fisher Scientific Recent Developments
11.2 PerkinElmer
11.2.1 PerkinElmer Corporation Information
11.2.2 PerkinElmer Business Overview
11.2.3 PerkinElmer High-throughput Screening (HTS) Assay Product Features and Attributes
11.2.4 PerkinElmer High-throughput Screening (HTS) Assay Revenue and Gross Margin (2020-2025)
11.2.5 PerkinElmer High-throughput Screening (HTS) Assay Revenue by Product in 2024
11.2.6 PerkinElmer High-throughput Screening (HTS) Assay Revenue by Application in 2024
11.2.7 PerkinElmer High-throughput Screening (HTS) Assay Revenue by Geographic Area in 2024
11.2.8 PerkinElmer High-throughput Screening (HTS) Assay SWOT Analysis
11.2.9 PerkinElmer Recent Developments
11.3 Agilent Technologies
11.3.1 Agilent Technologies Corporation Information
11.3.2 Agilent Technologies Business Overview
11.3.3 Agilent Technologies High-throughput Screening (HTS) Assay Product Features and Attributes
11.3.4 Agilent Technologies High-throughput Screening (HTS) Assay Revenue and Gross Margin (2020-2025)
11.3.5 Agilent Technologies High-throughput Screening (HTS) Assay Revenue by Product in 2024
11.3.6 Agilent Technologies High-throughput Screening (HTS) Assay Revenue by Application in 2024
11.3.7 Agilent Technologies High-throughput Screening (HTS) Assay Revenue by Geographic Area in 2024
11.3.8 Agilent Technologies High-throughput Screening (HTS) Assay SWOT Analysis
11.3.9 Agilent Technologies Recent Developments
11.4 Beckman Coulter
11.4.1 Beckman Coulter Corporation Information
11.4.2 Beckman Coulter Business Overview
11.4.3 Beckman Coulter High-throughput Screening (HTS) Assay Product Features and Attributes
11.4.4 Beckman Coulter High-throughput Screening (HTS) Assay Revenue and Gross Margin (2020-2025)
11.4.5 Beckman Coulter High-throughput Screening (HTS) Assay Revenue by Product in 2024
11.4.6 Beckman Coulter High-throughput Screening (HTS) Assay Revenue by Application in 2024
11.4.7 Beckman Coulter High-throughput Screening (HTS) Assay Revenue by Geographic Area in 2024
11.4.8 Beckman Coulter High-throughput Screening (HTS) Assay SWOT Analysis
11.4.9 Beckman Coulter Recent Developments
11.5 Tecan Group
11.5.1 Tecan Group Corporation Information
11.5.2 Tecan Group Business Overview
11.5.3 Tecan Group High-throughput Screening (HTS) Assay Product Features and Attributes
11.5.4 Tecan Group High-throughput Screening (HTS) Assay Revenue and Gross Margin (2020-2025)
11.5.5 Tecan Group High-throughput Screening (HTS) Assay Revenue by Product in 2024
11.5.6 Tecan Group High-throughput Screening (HTS) Assay Revenue by Application in 2024
11.5.7 Tecan Group High-throughput Screening (HTS) Assay Revenue by Geographic Area in 2024
11.5.8 Tecan Group High-throughput Screening (HTS) Assay SWOT Analysis
11.5.9 Tecan Group Recent Developments
11.6 Hamilton Company
11.6.1 Hamilton Company Corporation Information
11.6.2 Hamilton Company Business Overview
11.6.3 Hamilton Company High-throughput Screening (HTS) Assay Product Features and Attributes
11.6.4 Hamilton Company High-throughput Screening (HTS) Assay Revenue and Gross Margin (2020-2025)
11.6.5 Hamilton Company Recent Developments
11.7 Bio-Rad Laboratories
11.7.1 Bio-Rad Laboratories Corporation Information
11.7.2 Bio-Rad Laboratories Business Overview
11.7.3 Bio-Rad Laboratories High-throughput Screening (HTS) Assay Product Features and Attributes
11.7.4 Bio-Rad Laboratories High-throughput Screening (HTS) Assay Revenue and Gross Margin (2020-2025)
11.7.5 Bio-Rad Laboratories Recent Developments
11.8 BMG LABTECH
11.8.1 BMG LABTECH Corporation Information
11.8.2 BMG LABTECH Business Overview
11.8.3 BMG LABTECH High-throughput Screening (HTS) Assay Product Features and Attributes
11.8.4 BMG LABTECH High-throughput Screening (HTS) Assay Revenue and Gross Margin (2020-2025)
11.8.5 BMG LABTECH Recent Developments
11.9 Promega Corporation
11.9.1 Promega Corporation Corporation Information
11.9.2 Promega Corporation Business Overview
11.9.3 Promega Corporation High-throughput Screening (HTS) Assay Product Features and Attributes
11.9.4 Promega Corporation High-throughput Screening (HTS) Assay Revenue and Gross Margin (2020-2025)
11.9.5 Promega Corporation Recent Developments
11.10 Danaher
11.10.1 Danaher Corporation Information
11.10.2 Danaher Business Overview
11.10.3 Danaher High-throughput Screening (HTS) Assay Product Features and Attributes
11.10.4 Danaher High-throughput Screening (HTS) Assay Revenue and Gross Margin (2020-2025)
11.10.5 Company Ten Recent Developments
11.11 Axxam
11.11.1 Axxam Corporation Information
11.11.2 Axxam Business Overview
11.11.3 Axxam High-throughput Screening (HTS) Assay Product Features and Attributes
11.11.4 Axxam High-throughput Screening (HTS) Assay Revenue and Gross Margin (2020-2025)
11.11.5 Axxam Recent Developments
11.12 Merck Millipore
11.12.1 Merck Millipore Corporation Information
11.12.2 Merck Millipore Business Overview
11.12.3 Merck Millipore High-throughput Screening (HTS) Assay Product Features and Attributes
11.12.4 Merck Millipore High-throughput Screening (HTS) Assay Revenue and Gross Margin (2020-2025)
11.12.5 Merck Millipore Recent Developments
11.13 Aurora Biomed
11.13.1 Aurora Biomed Corporation Information
11.13.2 Aurora Biomed Business Overview
11.13.3 Aurora Biomed High-throughput Screening (HTS) Assay Product Features and Attributes
11.13.4 Aurora Biomed High-throughput Screening (HTS) Assay Revenue and Gross Margin (2020-2025)
11.13.5 Aurora Biomed Recent Developments
11.14 InvivoGen
11.14.1 InvivoGen Corporation Information
11.14.2 InvivoGen Business Overview
11.14.3 InvivoGen High-throughput Screening (HTS) Assay Product Features and Attributes
11.14.4 InvivoGen High-throughput Screening (HTS) Assay Revenue and Gross Margin (2020-2025)
11.14.5 InvivoGen Recent Developments
11.15 Biotek Instruments
11.15.1 Biotek Instruments Corporation Information
11.15.2 Biotek Instruments Business Overview
11.15.3 Biotek Instruments High-throughput Screening (HTS) Assay Product Features and Attributes
11.15.4 Biotek Instruments High-throughput Screening (HTS) Assay Revenue and Gross Margin (2020-2025)
11.15.5 Biotek Instruments Recent Developments
11.16 BPS Bioscience
11.16.1 BPS Bioscience Corporation Information
11.16.2 BPS Bioscience Business Overview
11.16.3 BPS Bioscience High-throughput Screening (HTS) Assay Product Features and Attributes
11.16.4 BPS Bioscience High-throughput Screening (HTS) Assay Revenue and Gross Margin (2020-2025)
11.16.5 BPS Bioscience Recent Developments
11.17 Eurofins Discovery
11.17.1 Eurofins Discovery Corporation Information
11.17.2 Eurofins Discovery Business Overview
11.17.3 Eurofins Discovery High-throughput Screening (HTS) Assay Product Features and Attributes
11.17.4 Eurofins Discovery High-throughput Screening (HTS) Assay Revenue and Gross Margin (2020-2025)
11.17.5 Eurofins Discovery Recent Developments
11.18 Cayman Chemical
11.18.1 Cayman Chemical Corporation Information
11.18.2 Cayman Chemical Business Overview
11.18.3 Cayman Chemical High-throughput Screening (HTS) Assay Product Features and Attributes
11.18.4 Cayman Chemical High-throughput Screening (HTS) Assay Revenue and Gross Margin (2020-2025)
11.18.5 Cayman Chemical Recent Developments
12 High-throughput Screening (HTS) AssayIndustry Chain Analysis
12.1 High-throughput Screening (HTS) Assay Industry Chain
12.2 Upstream Analysis
12.2.1 Upstream Key Suppliers
12.3 Middlestream Analysis
12.4 Downstream Sales Model and Distribution Networks
12.4.1 Sales Channels
12.4.2 Distributors
13 High-throughput Screening (HTS) Assay Market Dynamics
13.1 Industry Trends and Evolution
13.2 Market Growth Drivers and Emerging Opportunities
13.3 Market Challenges, Risks, and Restraints
14 Key Findings in the Global High-throughput Screening (HTS) Assay Study
15 Appendix
15.1 Research Methodology
15.1.1 Methodology/Research Approach
15.1.1.1 Research Programs/Design
15.1.1.2 Market Size Estimation
15.1.1.3 Market Breakdown and Data Triangulation
15.1.2 Data Source
15.1.2.1 Secondary Sources
15.1.2.2 Primary Sources
15.2 Author Details
FEATURED COMPANIES
Thermo Fisher Scientific
PerkinElmer Inc
Agilent Technologies
Beckman Coulter
Tecan Group
Hamilton Company
Bio Rad Laboratories
BMG LABTECH
Promega Corporation
Danaher
Axxam S.P.A.
Merck Millipore
Aurora Biomed
InvivoGen
Biotek Instruments
BPS Bioscience
Eurofins Discovery
Cayman Chemical
List of Tables
 Table 1. Global High-throughput Screening (HTS) Assay Market Size Growth Rate by Type, 2020 VS 2024 VS 2031 (US$ Million)
 Table 2. Global High-throughput Screening (HTS) Assay Market Size Growth Rate by Application, 2020 VS 2024 VS 2031 (US$ Million)
 Table 3. Global High-throughput Screening (HTS) Assay Revenue Grow Rate (CAGR) by Region: 2020 VS 2024 VS 2031 (US$ Million)
 Table 4. Global High-throughput Screening (HTS) Assay Revenue by Region (2020-2025) & (US$ Million)
 Table 5. Global High-throughput Screening (HTS) Assay Revenue by Region (2026-2031) & (US$ Million)
 Table 6. Emerging Market Revenue Grow Rate (CAGR) by Country (2020 VS 2024 VS 2031) (US$ Million)
 Table 7. Global High-throughput Screening (HTS) Assay Revenue by Players (2020-2025) & (US$ Million)
 Table 8. Global High-throughput Screening (HTS) Assay Revenue Market Share by Players (2020-2025)
 Table 9. Global Key Players’Ranking Shift (2023 vs. 2024) (Based on Revenue)
 Table 10. Global High-throughput Screening (HTS) Assay by Player Tier (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in High-throughput Screening (HTS) Assay as of 2024)
 Table 11. Global High-throughput Screening (HTS) Assay Average Gross Margin (%) by Player (2020 VS 2024)
 Table 12. Global High-throughput Screening (HTS) Assay Companies Headquarters
 Table 13. Global High-throughput Screening (HTS) Assay Market Concentration Ratio (CR5 and HHI)
 Table 14. Key Market Entrant/Exit (2020-2024) – Drivers & Impact Analysis
 Table 15. Key Mergers & Acquisitions, Expansion Plans, R&D Investment
 Table 16. Global High-throughput Screening (HTS) Assay Revenue by Type (2020-2025) & (US$ Million)
 Table 17. Global High-throughput Screening (HTS) Assay Revenue by Type (2026-2031) & (US$ Million)
 Table 18. Key Product Attributes and Differentiation
 Table 19. Global High-throughput Screening (HTS) Assay Revenue by Application (2020-2025) & (US$ Million)
 Table 20. Global High-throughput Screening (HTS) Assay Revenue by Application (2026-2031) & (US$ Million)
 Table 21. High-throughput Screening (HTS) Assay High-Growth Sectors Demand CAGR (2024-2031)
 Table 22. Top Customers by Region
 Table 23. Top Customers by Application
 Table 24. North America High-throughput Screening (HTS) Assay Growth Accelerators and Market Barriers
 Table 25. North America High-throughput Screening (HTS) Assay Revenue Grow Rate (CAGR) by Country (2020 VS 2024 VS 2031) (US$ Million)
 Table 26. Europe High-throughput Screening (HTS) Assay Growth Accelerators and Market Barriers
 Table 27. Europe High-throughput Screening (HTS) Assay Revenue Grow Rate (CAGR) by Country: 2020 VS 2024 VS 2031 (US$ Million)
 Table 28. Asia-Pacific High-throughput Screening (HTS) Assay Growth Accelerators and Market Barriers
 Table 29. Asia-Pacific High-throughput Screening (HTS) Assay Revenue Grow Rate (CAGR) by Region: 2020 VS 2024 VS 2031 (US$ Million)
 Table 30. Central and South America High-throughput Screening (HTS) Assay Investment Opportunities and Key Challenges
 Table 31. Central and South America High-throughput Screening (HTS) Assay Revenue Grow Rate (CAGR) by Country (2020 VS 2024 VS 2031) (US$ Million)
 Table 32. Middle East and Africa High-throughput Screening (HTS) Assay Investment Opportunities and Key Challenges
 Table 33. Middle East and Africa High-throughput Screening (HTS) Assay Revenue Grow Rate (CAGR) by Country (2020 VS 2024 VS 2031) (US$ Million)
 Table 34. Thermo Fisher Scientific Corporation Information
 Table 35. Thermo Fisher Scientific Description and Major Businesses
 Table 36. Thermo Fisher Scientific Product Features and Attributes
 Table 37. Thermo Fisher Scientific Revenue (US$ Million) and Gross Margin (2020-2025)
 Table 38. Thermo Fisher Scientific Revenue Proportion by Product in 2024
 Table 39. Thermo Fisher Scientific Revenue Proportion by Application in 2024
 Table 40. Thermo Fisher Scientific Revenue Proportion by Geographic Area in 2024
 Table 41. Thermo Fisher Scientific High-throughput Screening (HTS) Assay SWOT Analysis
 Table 42. Thermo Fisher Scientific Recent Developments
 Table 43. PerkinElmer Corporation Information
 Table 44. PerkinElmer Description and Major Businesses
 Table 45. PerkinElmer Product Features and Attributes
 Table 46. PerkinElmer Revenue (US$ Million) and Gross Margin (2020-2025)
 Table 47. PerkinElmer Revenue Proportion by Product in 2024
 Table 48. PerkinElmer Revenue Proportion by Application in 2024
 Table 49. PerkinElmer Revenue Proportion by Geographic Area in 2024
 Table 50. PerkinElmer High-throughput Screening (HTS) Assay SWOT Analysis
 Table 51. PerkinElmer Recent Developments
 Table 52. Agilent Technologies Corporation Information
 Table 53. Agilent Technologies Description and Major Businesses
 Table 54. Agilent Technologies Product Features and Attributes
 Table 55. Agilent Technologies Revenue (US$ Million) and Gross Margin (2020-2025)
 Table 56. Agilent Technologies Revenue Proportion by Product in 2024
 Table 57. Agilent Technologies Revenue Proportion by Application in 2024
 Table 58. Agilent Technologies Revenue Proportion by Geographic Area in 2024
 Table 59. Agilent Technologies High-throughput Screening (HTS) Assay SWOT Analysis
 Table 60. Agilent Technologies Recent Developments
 Table 61. Beckman Coulter Corporation Information
 Table 62. Beckman Coulter Description and Major Businesses
 Table 63. Beckman Coulter Product Features and Attributes
 Table 64. Beckman Coulter Revenue (US$ Million) and Gross Margin (2020-2025)
 Table 65. Beckman Coulter Revenue Proportion by Product in 2024
 Table 66. Beckman Coulter Revenue Proportion by Application in 2024
 Table 67. Beckman Coulter Revenue Proportion by Geographic Area in 2024
 Table 68. Beckman Coulter High-throughput Screening (HTS) Assay SWOT Analysis
 Table 69. Beckman Coulter Recent Developments
 Table 70. Tecan Group Corporation Information
 Table 71. Tecan Group Description and Major Businesses
 Table 72. Tecan Group Product Features and Attributes
 Table 73. Tecan Group Revenue (US$ Million) and Gross Margin (2020-2025)
 Table 74. Tecan Group Revenue Proportion by Product in 2024
 Table 75. Tecan Group Revenue Proportion by Application in 2024
 Table 76. Tecan Group Revenue Proportion by Geographic Area in 2024
 Table 77. Tecan Group High-throughput Screening (HTS) Assay SWOT Analysis
 Table 78. Tecan Group Recent Developments
 Table 79. Hamilton Company Corporation Information
 Table 80. Hamilton Company Description and Major Businesses
 Table 81. Hamilton Company Product Features and Attributes
 Table 82. Hamilton Company Revenue (US$ Million) and Gross Margin (2020-2025)
 Table 83. Hamilton Company Recent Developments
 Table 84. Bio-Rad Laboratories Corporation Information
 Table 85. Bio-Rad Laboratories Description and Major Businesses
 Table 86. Bio-Rad Laboratories Product Features and Attributes
 Table 87. Bio-Rad Laboratories Revenue (US$ Million) and Gross Margin (2020-2025)
 Table 88. Bio-Rad Laboratories Recent Developments
 Table 89. BMG LABTECH Corporation Information
 Table 90. BMG LABTECH Description and Major Businesses
 Table 91. BMG LABTECH Product Features and Attributes
 Table 92. BMG LABTECH Revenue (US$ Million) and Gross Margin (2020-2025)
 Table 93. BMG LABTECH Recent Developments
 Table 94. Promega Corporation Corporation Information
 Table 95. Promega Corporation Description and Major Businesses
 Table 96. Promega Corporation Product Features and Attributes
 Table 97. Promega Corporation Revenue (US$ Million) and Gross Margin (2020-2025)
 Table 98. Promega Corporation Recent Developments
 Table 99. Danaher Corporation Information
 Table 100. Danaher Description and Major Businesses
 Table 101. Danaher Product Features and Attributes
 Table 102. Danaher Revenue (US$ Million) and Gross Margin (2020-2025)
 Table 103. Danaher Recent Developments
 Table 104. Axxam Corporation Information
 Table 105. Axxam Description and Major Businesses
 Table 106. Axxam Product Features and Attributes
 Table 107. Axxam Revenue (US$ Million) and Gross Margin (2020-2025)
 Table 108. Axxam Recent Developments
 Table 109. Merck Millipore Corporation Information
 Table 110. Merck Millipore Description and Major Businesses
 Table 111. Merck Millipore Product Features and Attributes
 Table 112. Merck Millipore Revenue (US$ Million) and Gross Margin (2020-2025)
 Table 113. Merck Millipore Recent Developments
 Table 114. Aurora Biomed Corporation Information
 Table 115. Aurora Biomed Description and Major Businesses
 Table 116. Aurora Biomed Product Features and Attributes
 Table 117. Aurora Biomed Revenue (US$ Million) and Gross Margin (2020-2025)
 Table 118. Aurora Biomed Recent Developments
 Table 119. InvivoGen Corporation Information
 Table 120. InvivoGen Description and Major Businesses
 Table 121. InvivoGen Product Features and Attributes
 Table 122. InvivoGen Revenue (US$ Million) and Gross Margin (2020-2025)
 Table 123. InvivoGen Recent Developments
 Table 124. Biotek Instruments Corporation Information
 Table 125. Biotek Instruments Description and Major Businesses
 Table 126. Biotek Instruments Product Features and Attributes
 Table 127. Biotek Instruments Revenue (US$ Million) and Gross Margin (2020-2025)
 Table 128. Biotek Instruments Recent Developments
 Table 129. BPS Bioscience Corporation Information
 Table 130. BPS Bioscience Description and Major Businesses
 Table 131. BPS Bioscience Product Features and Attributes
 Table 132. BPS Bioscience Revenue (US$ Million) and Gross Margin (2020-2025)
 Table 133. BPS Bioscience Recent Developments
 Table 134. Eurofins Discovery Corporation Information
 Table 135. Eurofins Discovery Description and Major Businesses
 Table 136. Eurofins Discovery Product Features and Attributes
 Table 137. Eurofins Discovery Revenue (US$ Million) and Gross Margin (2020-2025)
 Table 138. Eurofins Discovery Recent Developments
 Table 139. Cayman Chemical Corporation Information
 Table 140. Cayman Chemical Description and Major Businesses
 Table 141. Cayman Chemical Product Features and Attributes
 Table 142. Cayman Chemical Revenue (US$ Million) and Gross Margin (2020-2025)
 Table 143. Cayman Chemical Recent Developments
 Table 144. Raw Materials Key Suppliers
 Table 145. Distributors List
 Table 146. Market Trends and Market Evolution
 Table 147. Market Drivers and Opportunities
 Table 148. Market Challenges, Risks, and Restraints
 Table 149. Research Programs/Design for This Report
 Table 150. Key Data Information from Secondary Sources
 Table 151. Key Data Information from Primary Sources


List of Figures
 Figure 1. High-throughput Screening (HTS) Assay Product Picture
 Figure 2. Global High-throughput Screening (HTS) Assay Market Size Growth Rate by Type, 2020 VS 2024 VS 2031 (US$ Million)
 Figure 3. Biochemical Assay Product Picture
 Figure 4. Phenotyping Assay Product Picture
 Figure 5. Binding Assay Product Picture
 Figure 6. Aell-based Assay Product Picture
 Figure 7. Others Product Picture
 Figure 8. Global High-throughput Screening (HTS) Assay Market Size Growth Rate by Application, 2020 VS 2024 VS 2031 (US$ Million)
 Figure 9. Drug Discovery
 Figure 10. Identifying New Drug Targets
 Figure 11. Toxicology Research
 Figure 12. Others
 Figure 13. High-throughput Screening (HTS) Assay Report Years Considered
 Figure 14. Global High-throughput Screening (HTS) Assay Revenue, (US$ Million), 2020 VS 2024 VS 2031
 Figure 15. Global High-throughput Screening (HTS) Assay Revenue (2020-2031) & (US$ Million)
 Figure 16. Global High-throughput Screening (HTS) Assay Revenue (CAGR) by Region: 2020 VS 2024 VS 2031 (US$ Million)
 Figure 17. Global High-throughput Screening (HTS) Assay Revenue Market Share by Region (2020-2031)
 Figure 18. Global High-throughput Screening (HTS) Assay Revenue Market Share Ranking (2024)
 Figure 19. Tier Distribution by Revenue Contribution (2020 VS 2024)
 Figure 20. Biochemical Assay Revenue Market Share by Player in 2024
 Figure 21. Phenotyping Assay Revenue Market Share by Player in 2024
 Figure 22. Binding Assay Revenue Market Share by Player in 2024
 Figure 23. Aell-based Assay Revenue Market Share by Player in 2024
 Figure 24. Others Revenue Market Share by Player in 2024
 Figure 25. Global High-throughput Screening (HTS) Assay Revenue Market Share by Type (2020-2031)
 Figure 26. Global High-throughput Screening (HTS) Assay Revenue Market Share by Application (2020-2031)
 Figure 27. North America High-throughput Screening (HTS) Assay Revenue YoY (2020-2031) & (US$ Million)
 Figure 28. North America Top 5 Players High-throughput Screening (HTS) Assay Revenue (US$ Million) in 2024
 Figure 29. North America High-throughput Screening (HTS) Assay Revenue (US$ Million) by Type (2020 - 2031)
 Figure 30. North America High-throughput Screening (HTS) Assay Revenue (US$ Million) by Application (2020-2031)
 Figure 31. US High-throughput Screening (HTS) Assay Revenue (2020-2031) & (US$ Million)
 Figure 32. Canada High-throughput Screening (HTS) Assay Revenue (2020-2031) & (US$ Million)
 Figure 33. Mexico High-throughput Screening (HTS) Assay Revenue (2020-2031) & (US$ Million)
 Figure 34. Europe High-throughput Screening (HTS) Assay Revenue YoY (2020-2031) & (US$ Million)
 Figure 35. Europe Top 5 Players High-throughput Screening (HTS) Assay Revenue (US$ Million) in 2024
 Figure 36. Europe High-throughput Screening (HTS) Assay Revenue (US$ Million) by Type (2020-2031)
 Figure 37. Europe High-throughput Screening (HTS) Assay Revenue (US$ Million) by Application (2020-2031)
 Figure 38. Germany High-throughput Screening (HTS) Assay Revenue (2020-2031) & (US$ Million)
 Figure 39. France High-throughput Screening (HTS) Assay Revenue (2020-2031) & (US$ Million)
 Figure 40. U.K. High-throughput Screening (HTS) Assay Revenue (2020-2031) & (US$ Million)
 Figure 41. Italy High-throughput Screening (HTS) Assay Revenue (2020-2031) & (US$ Million)
 Figure 42. Russia High-throughput Screening (HTS) Assay Revenue (2020-2031) & (US$ Million)
 Figure 43. Asia-Pacific High-throughput Screening (HTS) Assay Revenue YoY (2020-2031) & (US$ Million)
 Figure 44. Asia-Pacific Top 8 Players High-throughput Screening (HTS) Assay Revenue (US$ Million) in 2024
 Figure 45. Asia-Pacific High-throughput Screening (HTS) Assay Revenue (US$ Million) by Type (2020-2031)
 Figure 46. Asia-Pacific High-throughput Screening (HTS) Assay Revenue (US$ Million) by Application (2020-2031)
 Figure 47. Indonesia High-throughput Screening (HTS) Assay Revenue (2020-2031) & (US$ Million)
 Figure 48. Japan High-throughput Screening (HTS) Assay Revenue (2020-2031) & (US$ Million)
 Figure 49. South Korea High-throughput Screening (HTS) Assay Revenue (2020-2031) & (US$ Million)
 Figure 50. Australia High-throughput Screening (HTS) Assay Revenue (2020-2031) & (US$ Million)
 Figure 51. India High-throughput Screening (HTS) Assay Revenue (2020-2031) & (US$ Million)
 Figure 52. Indonesia High-throughput Screening (HTS) Assay Revenue (2020-2031) & (US$ Million)
 Figure 53. Vietnam High-throughput Screening (HTS) Assay Revenue (2020-2031) & (US$ Million)
 Figure 54. Malaysia High-throughput Screening (HTS) Assay Revenue (2020-2031) & (US$ Million)
 Figure 55. Philippines High-throughput Screening (HTS) Assay Revenue (2020-2031) & (US$ Million)
 Figure 56. Singapore High-throughput Screening (HTS) Assay Revenue (2020-2031) & (US$ Million)
 Figure 57. Central and South America High-throughput Screening (HTS) Assay Revenue YoY (2020-2031) & (US$ Million)
 Figure 58. Central and South America Top 5 Players High-throughput Screening (HTS) Assay Revenue (US$ Million) in 2024
 Figure 59. Central and South America High-throughput Screening (HTS) Assay Revenue (US$ Million) by Type (2020-2031)
 Figure 60. Central and South America High-throughput Screening (HTS) Assay Revenue (US$ Million) by Application (2020-2031)
 Figure 61. Brazil High-throughput Screening (HTS) Assay Revenue (2020-2025) & (US$ Million)
 Figure 62. Argentina High-throughput Screening (HTS) Assay Revenue (2020-2025) & (US$ Million)
 Figure 63. Middle East and Africa High-throughput Screening (HTS) Assay Revenue YoY (2020-2031) & (US$ Million)
 Figure 64. Middle East and Africa Top 5 Players High-throughput Screening (HTS) Assay Revenue (US$ Million) in 2024
 Figure 65. South America High-throughput Screening (HTS) Assay Revenue (US$ Million) by Type (2020-2031)
 Figure 66. Middle East and Africa High-throughput Screening (HTS) Assay Revenue (US$ Million) by Application (2020-2031)
 Figure 67. GCC Countries High-throughput Screening (HTS) Assay Revenue (2020-2025) & (US$ Million)
 Figure 68. Israel High-throughput Screening (HTS) Assay Revenue (2020-2025) & (US$ Million)
 Figure 69. Egypt High-throughput Screening (HTS) Assay Revenue (2020-2025) & (US$ Million)
 Figure 70. South Africa High-throughput Screening (HTS) Assay Revenue (2020-2025) & (US$ Million)
 Figure 71. High-throughput Screening (HTS) Assay Industry Chain Mapping
 Figure 72. Channels of Distribution (Direct Vs Distribution)
 Figure 73. Bottom-up and Top-down Approaches for This Report
 Figure 74. Data Triangulation
 Figure 75. Key Executives Interviewed
SELECT A FORMAT
Added to Cart
Electronic (PDF)

$4900

This license allows only one user to access the PDF.
Electronic (PDF)

$7350

This license allows 1 - 5 user to access the PDF, license is suitable for small groups of 5 users working together
Electronic (PDF)

$9800

This license allows users/teams in a same Enterprise to use this report, various departments within an enterpise can use this report
Add to Cart
Buy Now (15% Discount)
INQUIRE FOR DISCOUNT

HAVE A QUERY?

INQUIRE ABOUT REPORT EMAIL US

OUR CUSTOMER

Lukasiewicz Research Network

SIMILAR REPORTS

Global High Throughput Screening Market Research Report 2024
Global High Throughput Screening Services for Drug Discovery Market Research Report 2024
Global High Throughput Cell Screening Instrument Market Research Report 2024
High Throughput Screening HTS Global Market Share and Ranking Overall Sales and Demand Forecast 2024 2030
Global High Throughput Screening HTS Service Market Research Report 2024
Global High Throughput Titration Systems Market Research Report 2024
Global In Vitro Assay Development Service Market Research Report 2024
Global High Content Analysis HCA System Market Research Report 2024
Global High Content Screening HCS Microplates Market Research Report 2025
Cell based Assay Global Market Share and Ranking Overall Sales and Demand Forecast 2024 2030
Global High Content Analysis System Market Research Report 2025
Global HTS Microplate Readers Market Research Report 2024
Global High Content Imaging Instruments Market Research Report 2024
High Content Screening Platform Global Market Share and Ranking Overall Sales and Demand Forecast 2024 2030
Global High Content Imaging HCI System Market Research Report 2024
Global High Throughput Imaging Services Market Research Report 2024
Global Cytotoxicity Assay Market Insights Forecast to 2030
High Content Screening System Global Market Share and Ranking Overall Sales and Demand Forecast 2024 2030
Global High Throughput Sequencing HTS Market Research Report 2024
High Content Screening Instruments Global Market Share and Ranking Overall Sales and Demand Forecast 2024 2030
Call
Buy Now
REQUEST FREE SAMPLE REPORT
Support Contacts
U.S. (TOLL FREE)
+1 (425) 388-2538
THE COMPANY
OUR PRODUCTS
CUSTOMER SUPPORT
POLICES
THE COMPANY
CUSTOMER SUPPORT
OUR PRODUCTS
POLICES
Copyright © 2018 Valuates.com. All Rights Reserved.
Sitemap - Privacy Policy - Terms & Conditions